Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Keros+Therapeutics+%28KROS%29+Announces+U.S.+FDA+Fast+Track+Designation+for+KER-050+in+Lower-Risk+Myelodysplastic+Syndromes/22929699.html for the full story.

Eins ist Fakt
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Keros+Therapeutics+%28KROS%29+Announces+U.S.+FDA+Fast+Track+Designation+for+KER-050+in+Lower-Risk+Myelodysplastic+Syndromes/22929699.html for the full story.